METHOD FOR SECONDARY PREVENTION OF ATHEROTHROMBOSIS IN FEMALE PATIENTS WITH CARDIOVASCULAR DISEASES

摘要

A method for the secondary prevention of atherothrombosis in the female patients with cardiovascular diseases comprises the assessment of the intravascular hemostasis prior to the treatment based on platelet aggregation index calculated according to the conventional formula. In the setting of the symptomatic complex therapy, acetylsalicylic acid at the minimal therapeutically effective dose that is safe in terms of the evidence-based medicine is used as antiaggregant.